{"organizations": [], "uuid": "9c64714dbd12d2ce8d1e1704cc64ccb0881641f0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bayer-disagrees-with-efsas-updated/brief-bayer-disagrees-with-efsas-updated-risk-assessment-conclusions-for-imidacloprid-and-clothianidin-idUSFWN1QI0UZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Bayer Disagrees With EFSA’S Updated Risk Assessment Conclusions For Imidacloprid And Clothianidin‍​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.978, "site_type": "news", "published": "2018-02-28T19:11:00.000+02:00", "replies_count": 0, "uuid": "9c64714dbd12d2ce8d1e1704cc64ccb0881641f0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bayer-disagrees-with-efsas-updated/brief-bayer-disagrees-with-efsas-updated-risk-assessment-conclusions-for-imidacloprid-and-clothianidin-idUSFWN1QI0UZ", "ord_in_thread": 0, "title": "BRIEF-Bayer Disagrees With EFSA’S Updated Risk Assessment Conclusions For Imidacloprid And Clothianidin‍​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "efsa", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "bayer ag", "sentiment": "negative"}, {"name": "bayer", "sentiment": "negative"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - BAYER AG:\n* BAYER -FUNDAMENTALLY DISAGREES WITH EFSA’S UPDATED RISK ASSESSMENT CONCLUSIONS FOR ACTIVE SUBSTANCES IMIDACLOPRID AND CLOTHIANIDIN‍​\n* BAYER - WILL CONTINUE TO WORK WITH FARMERS, BEEKEEPERS AND REGULATORS ON SOLUTIONS THAT HAVE POSITIVE IMPACT ON BEE HEALTH Source text - bit.ly/2oBjpL1 Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2oBjpL1"], "published": "2018-02-28T19:11:00.000+02:00", "crawled": "2018-03-01T21:12:58.006+02:00", "highlightTitle": ""}